PRME Kronos AI forecast
A 30-trading-day price forecast for Prime Medicine Inc. (PRME) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Prime Medicine Inc. at $3.18 on 2026-12-08, −26.9% from the last close of $4.35 on 2026-10-27. Eight out of ten sampled paths end between $2.95 and $3.41, and 0 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of PRME
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $3.93 | $3.75 | $4.01 |
| 2026-11-10 | $3.48 | $3.34 | $3.53 |
| 2026-11-17 | $3.36 | $3.20 | $3.49 |
| 2026-11-24 | $3.30 | $3.15 | $3.46 |
| 2026-12-01 | $3.19 | $3.06 | $3.33 |
| 2026-12-08 | $3.18 | $2.95 | $3.41 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for PRME?
- Kronos AI's median forecast for PRME is $3.18 in 30 trading days, −26.9% from the last close, with a 10–90% range of $2.95 to $3.41.
- Is the PRME Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- AMGN — Amgen Inc.
- GILD — Gilead Sciences Inc.
- MRNA — Moderna Inc.
- ARGX — argenx SE American Depositary Shares
- RVMD — Revolution Medicines Inc.
- BIIB — Biogen Inc.